Tomas Bos
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- CAR-T cell therapy research
Papers in
-
- Protein Degradation and Inhibitors 4
- bioluminescence and chemiluminescence research 3
- RNA Research and Splicing 3
- Histone Deacetylase Inhibitors Research 3
- RNA Interference and Gene Delivery 2
-
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Carlo Heirman (4 shared papers)Kris Thielemans (3 shared papers)Elke De Bruyne (6 shared papers)Karin Vanderkerken (6 shared papers)Tony Lahoutte (4 shared papers)Sandra Tuyaerts (1 shared paper)Aude Bonehill (1 shared paper)Bart Neyns (1 shared paper)
- Journals
- Blood (2 papers)Molecular Therapy (1 paper)Clinical Cancer Research (1 paper)Gastroenterology (1 paper)Advances in experimental medicine and biology (1 paper)
- Partner nations
- BelgiumUnited StatesSingapore
In The Last Decade
Tomas Bos
15 papers receiving 649 citations
Peers
Comparison fields: 5 of 70
- Immunology 187
- Oncology 174
- Molecular Biology 424
- Hematology 62
- Genetics 107
Countries citing papers authored by Tomas Bos
This map shows the geographic impact of Tomas Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Bos more than expected).
Fields of papers citing papers by Tomas Bos
This network shows the impact of papers produced by Tomas Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Bos. The network helps show where Tomas Bos may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomas Bos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 151 | |
| 2 | 2010 | 84 | |
| 3 | 2008 | 74 | |
| 4 | 2009 | 64 | |
| 5 | 2017 | 50 | |
| 6 | 2016 | 42 | |
| 7 | 2008 | 38 | |
| 8 | 2012 | 35 | |
| 9 | 2016 | 29 | |
| 10 | 2012 | 26 | |
| 11 | 2010 | 24 | |
| 12 | 2011 | 21 | |
| 13 | 2009 | 15 | |
| 14 | 2014 | 4 | |
| 15 | 2007 | 2 | |
| 16 | 2009 | 0 |
About Tomas Bos
Tomas Bos is a scholar working on Molecular Biology, Hematology, Genetics, Immunology and Biomedical Engineering, having authored 16 papers that have together received 659 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (4 papers), bioluminescence and chemiluminescence research (3 papers), Virus-based gene therapy research (3 papers), RNA Research and Splicing (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Immunotherapy and Immune Responses (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Immunology (187 citations), Oncology (174 citations), Molecular Biology (424 citations), Hematology (62 citations) and Genetics (107 citations). Tomas Bos has collaborated with scholars based in Belgium, United States and Singapore. Frequent co-authors include Carlo Heirman, Kris Thielemans, Elke De Bruyne, Karin Vanderkerken, Tony Lahoutte, Sandra Tuyaerts, Aude Bonehill, Bart Neyns, Karel Fostier and An M. T. Van Nuffel. Their work appears in journals such as Blood, Molecular Therapy, Clinical Cancer Research, Gastroenterology and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.